Podcast
Cardio Buzz
Hosted by Dr. Hussien Heshmat · EN
A channel for cardiology news and updates.
10episodes
Episodes
Newest firstAll episodes
Decoding Hypertension: The Surprising Truth About Primary Aldosteronism
Aug 800:20:43Tap to summarize00:00 Introduction to Hypertension 00:38 Welcome to Cardio Buzz 01:01 Understanding Primary Aldosteronism 02:27 Health Risks of Primary Aldosteronism 02:59 Screening for Primary Aldosteronism 05:00 Diagnosis and Interpretation 09:46 Adrenal Vein Sampling 14:22 Surgical and Medical Treatments 19:50 Conclusion and Final Thoughts
Transcribe →
My heart failure patient is hypotensive, Now What?
Mar 30, 202500:17:30Tap to summarizeIs low blood pressure hindering your heart failure treatment? How do you balance life-saving medications with hypotension? We explore the definitions, causes, and practical solutions to optimize patient care. Learn how to navigate ARNI, beta-blockers, SGLT2 inhibitors, and MRAs effectively.
Transcribe →
Do Medications Leave a Legacy? What You Should Know
Mar 7, 202500:11:00Tap to summarizeIn this episode of Cardio Buzz, we explore the intriguing concept of the 'legacy effect' of medications like those used in treating diabetes, hypertension, hypercholesterolemia, and chronic kidney disease. We'll delve into landmark studies like the UKPDS, Steno-2, and more, examining the lasting impacts of medications such as Repatha, Candesartan, and Empagliflozin. Learn how these drugs contribute to disease regression, modify genes, and prevent non-fatal events to grant long-term protective effects. 00:00 Introduction: The Challenge of Lifelong Medication 00:57 Exploring the Legacy Effect of Medications 01:33 Diabetes Medications: Long-Term Benefits 03:15 Hypertension Medications: Persistent Effects 03:58 Cholesterol Medications: Lasting Impact 04:49 Kidney Disease Medications: Prolonged Benefits 06:12 Understanding the Legacy Effect Mechanism 09:13 Implications and Final Thoughts
Transcribe →
Ditch the Dutch! Familial Hypercholesterolemia made easy
Feb 27, 202500:06:06Tap to summarize"This week, we delve into the complexities of Familial Hypercholesterolemia (FH) diagnosis and challenge the conventional Dutch Lipid Clinic Network Score. 🩺 Our analysis of a recent Austrian study reveals significant limitations in the score's practical application, including inconsistent scoring and poor record completion. 📝 Key findings: 📊 A single off-treatment LDL cholesterol level of 190 mg/dL demonstrates comparable, and potentially superior, performance to the complex Dutch Lipid Score in identifying individuals with genetically confirmed FH. ✅ This simplified approach offers enhanced index case identification and facilitates timely referrals for genetic testing. 💡 We explore how a simpler, LDL-focused strategy could change clinical practice. This episode is crucial for cardiologists and lipid specialists seeking to streamline FH screening and improve patient outcomes. 🎧 Tune in to learn more! We also discuss the need for further studies to validate this approach and assess its impact on diagnosis rates and cardiovascular outcomes. 🔬 Listen now to 'Ditching the Dutch: FH Diagnosis made easy' and join the conversation on the future of FH screening. #Cardiology #FH #Lipidology #MedicalResearch #ClinicalPractice #Diagnosis 🗣️"
Transcribe →
The biggest update of the year from the ESC 2024 London
Sep 4, 202400:24:28Tap to summarizeJoin us in this episode of Cardio Buzz as we bring you the latest updates from the European Society of Cardiology conference held in London. Discover groundbreaking clinical trials and new guidelines that promise to reshape the practice of cardiology. We will break down the ten most impactful clinical trials and four new guidelines on hypertension, chronic coronary disease, atrial fibrillation, and peripheral/aortic diseases. Stay ahead in your field with our concise and insightful analysis. Subscribe, like, and hit the notification bell to stay informed on all cardiology advancements. 00:00 Introduction to the European Society of Cardiology Conference 00:59 Top 10 Late-Breaking Clinical Trials 04:41 New Guidelines Overview 05:38 Hypertension Guidelines 09:30 Chronic Coronary Artery Disease Guidelines 15:08 Peripheral Arterial and Aortic Disease Guidelines 20:33 Atrial Fibrillation Guidelines 23:58 Conclusion and Next Steps
Transcribe →Are Stem Cells the Ultimate Game Changer?
Aug 17, 202400:22:15Tap to summarizeIn this episode of Cardio Buzz, the discussion focuses on the potential of stem cell therapy to transform cardiology. Host Dr. Hussain interviews Dr. Yahya Kiwan, an experienced cardiologist and stem cell research advocate. They explore the application of stem cells in treating advanced heart conditions, including post-myocardial infarction and chronic heart failure. The episode covers the sources of stem cells, their harvesting and injection techniques, clinical trial results, and success stories. Dr. Kiwan addresses the ethical considerations and the future of regenerative medicine, emphasizing the need for greater awareness and education in the field. The episode concludes with information on upcoming educational opportunities and fellowships in regenerative cardiology. 00:48 The Promise of Stem Cells in Cardiology 01:31 Interview with Dr. Yahya Kiwan 04:13 Sources and Types of Stem Cells 05:55 Stem Cell Therapy Techniques 10:45 Current Applications and Success Stories 17:18 Future Perspectives and Ethical Considerations 19:38 Learning More About Regenerative Medicine 21:20 Conclusion and Next Steps
Transcribe →From Basic to Advanced: Unpacking Resuscitation (CPR) Challenges with Dr. Naeem Toosy
Jun 8, 202400:18:31Tap to summarizeIn this episode of CardioBuzz, host Dr. Hussien discusses advanced CPR techniques and challenges from a cardiologist's perspective, featuring Dr. Naeem Toosy, a consultant in emergency medicine. The conversation delves into critical aspects like when to stop resuscitation, use of mechanical circulatory support devices, and the effectiveness of mechanical chest compression devices. Dr. Tusi outlines the significance of early recognition, the role of the public in initiating CPR, and the potential benefits of ECMO during CPR. He underscores the need for national-level education on CPR and the importance of the Good Samaritan law in encouraging public intervention during cardiac arrests. 00:00 Introduction to CardioBuzz 00:08 Overview of CPR Challenges 00:33 Introducing Dr. Naeem Toosy 01:36 Importance of Brain Resuscitation 03:11 When to Stop Resuscitation 06:20 Mechanical Chest Compression Devices 07:49 ECMO in CPR 13:04 National Strategies to Reduce Cardiovascular Mortality 18:04 Conclusion and Final Thoughts
Transcribe →"From Beetroot to Breakthrough: Dr. Daniel Jones’ Findings on Preventing Contrast Nephropathy"
May 26, 202400:15:27Tap to summarizeIn this episode of Cardio Buzz, host and guest Dr. Daniel Jones discuss contrast nephropathy, a kidney injury caused by contrast agents used in medical imaging, and a promising intervention to reduce its incidence. Dr. Jones explains that inorganic nitrates, which are naturally found in green leafy vegetables, have shown significant potential in preventing contrast-induced nephropathy and associated acute kidney injuries in a recent study. This study involved 640 high-risk patients and demonstrated that inorganic nitrates reduced kidney injuries by 60% and improved long-term cardiovascular outcomes. The episode concludes with a conversation about the practical implications and future research plans for this intervention.
Transcribe →Acute Coronary Syndromes Part 1
Apr 20, 202400:20:08Tap to summarizeNo description available
Transcribe →
Plastics in our hearts
Apr 20, 202400:06:47Tap to summarizeMicroplastics are small pieces of plastic less than five millimeters in size that result from the degradation of larger plastic items. Derived from synthetic materials such as polyethylene and polyvinyl chloride, plastics are known for their durability and low cost but pose significant environmental and health risks due to their inability to biodegrade. Microplastics, including even smaller nanoplastics, are found everywhere - in our food, water, air, and even within the human body, where they can be ingested, inhaled, or absorbed through the skin. Italian researchers published their work in March 2024, found microplastics in the atherosclerotic plaques of patients with carotid artery stenosis. This presence of micro and nanoplastics was associated with higher levels of inflammation and an increased risk of heart attacks and strokes. While this finding indicates a correlation rather than causation, it raises concerns about the potential health impacts of microplastics. We provide practical advice on minimizing exposure to microplastics, such as avoiding single-use plastics, choosing products with minimal or no plastic packaging, and opting for natural fibers over synthetic ones. 00:00 Introduction to Plastics: Types and Properties 00:26 The Environmental and Health Impact of Microplastics 01:39 Investigating Microplastics in Human Arteries: A Groundbreaking Study 02:25 Study Findings: Microplastics in Atherosclerotic Plaques 03:12 Implications of the Study: Association vs. Causation 03:44 Practical Steps to Minimize Microplastic Exposure 04:47 Conclusion: The Challenge of Avoiding Microplastics
Transcribe →